Breast Cancer
Conditions
Interventions
Experimental group:The most sensitive traditional Chinese Medicine
control group:Blank control
Sponsors
Huashan Hospital, Fudan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The completed clinical data; (2) The histopathological specimens were diagnosed as breast cancer, and the physical status score was 0 -2 (3) Those who had previously received the first-line chemotherapy failed and planned to take the second-line chemotherapy this time; (4) TNM stage was stage IV; (5) there was no primary tumor in other parts; (6) oral Chinese medicine and Chinese patent medicine treatment were not given in three months before enrollment; (7) full informed consent and informed consent were signed., can accept chemotherapy.
Exclusion criteria
Exclusion criteria: (1) Patients in lactation and pregnancy; (2) Obvious infection focus; (3) patients with obvious cognitive impairment; (4) Patients with severe heart, liver and kidney function damage (cardiac function 3-4, ALT and / or ast more than 1.5 times higher than the normal upper limit, Cr more than the normal upper limit); (5) Other conditions that the researchers think are not suitable for the group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to Progression;Progression free survival;QOL;TCM syndrome score; | — |
Secondary
| Measure | Time frame |
|---|---|
| disease control rate;disease control rate;Overall survival;CA125;CA153;CA724;AFP;CEA; | — |
Countries
China
Contacts
Public ContactXianjun Sun
Huashan Hospital, Fudan University
Outcome results
None listed